FR EN
MI COMMUNITY
By creating this super innovation centre "outside the walls", which is Marseille Immunopole, we leverage our capabilities to ensure better and faster innovation.

Bruno LACARELLE
AP-HM, AMU

MI COMMUNITY
A therapeutic revolution is happening.

Bertrand NADEL
CIML, Institut Carnot CALYM, Cancéropole PACA

MI COMMUNITY
The Explore covid-19 project was born from combining the forces of Marseille Immunopôle. It should lead us to better understand this new disease and improve the prognosis of our patients.

Julien CARVELLI
AP-HM

MI COMMUNITY
Today Marseille Immunopôle is a great opportunity to challenge our discipline with novel perspectives.

Daniel OLIVE
AMU, IPC, CRCM

MI COMMUNITY
The Pioneer Project is unique as a strong public/private partnership between academia, a medical cancer center, 3 biotechs and a major pharma

Bernard A. FOX
Providence Cancer Institute, Portland, Oregon | UbiVac

MI COMMUNITY
Education is also one of the strategic components of the Marseille Immunopole project.

Françoise DIGNAT-GEORGE
AMU, AP-HM, C2VN

Newsletter
Stay informed
Subscribe
MI COMMUNITY
Veracyte (formerly HaliodDx) is a key player in the MI ecosystem that allows both personalized immunotherapies utilization and acceleration of their development.

Vincent FERT
Veracyte

MI COMMUNITY
Each year, a large number of clinical trials are conducted by APHM clinicians alone or in partnership with industry players in biopharmaceuticals.

Frédéric VELY
AMU, AP-HM, CIML

MI COMMUNITY
Being primarily centred on the patient, my work combines the short-term management of the disease and the long-term of clinical research.

Catherine FARNARIER
AP-HM

MI COMMUNITY
MI is a diamond of the new Metropolis, offering a unique opportunity to drive science forward and provide more effective therapeutic options for our cancer patients.

Delphine BADINAND
APHM

Update of The Pioneer Project: 444 patients in the biomarker program, 80 patients in the umbrella clinical trial Read more
MI COMMUNITY
“Projects like PIONeeR allow us to contribute to the understanding of resistance to immunotherapy while opening clinical research to patients in Corsica, who, until recently, had no choice other than to fly to Marseille or Paris for such opportunities.”

Stéphane PROVENT
Centre Hospitalier, Clinique Maymard, Bastia

MI COMMUNITY
Our study models help to identify new potential therapeutic targets in preclinical models of personalized medicine.

Michel AURRAND-LIONS
AMU, IPC, CRCM

MI COMMUNITY
Today, the Covid-19 pandemic serves as an eye-opener, once again demonstrating the strength of the Marseille Immunopôle collective

Nassima CHOUAKI BENMANSOUR
AP-HM

MI COMMUNITY
Unique cluster in the world exclusively dedicated to basic and applied immunology, MI results from an efficient territorial game between research, industry, and the institutional stakeholders in economy and innovation.

Jacques PFISTER
CCI Marseille Provence